Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer

Addition of Nivolumab to Neoadjuvant Chemotherapy in NSCLC: Results of CheckMate-816

Cardiac Toxicity of Lung Cancer Radiotherapy

Hippocampal-Sparing Brain Irradiation: The Future of Brain Metastases Treatment and Prevention?

Second-Line, Biomarker-Driven Therapies for Squamous NSCLC: Report on Lung-MAP SWOG S1400

China’s Domestic PD-1/PD-L1 Inhibitors Demanding Global Attention

Prophylactic Radiotherapy: A Case for Patients at High Risk of Brain Metastases

Biomarkers May Illuminate the Path Forward for PARP Inhibitors in SCLC

The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Con Side

The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Pro Side

NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment

Voice from Asia: Combination of Immune Checkpoint Inhibitors With Chemotherapy for Advanced Non-squamous NSCLC